Shasun is a pharmaceutical company that specializes in the development and manufacturing of formulations for solid dosage products. The company is a vertically integrated formulations partner for the pharmaceutical industry, with a strong focus on Europe, North America, Japan, and other regulated markets. Their services encompass a wide range of activities including formulation research and development, analytical method development and validation, scale-up and technology transfer, as well as clinical supplies manufacturing and full-scale commercial manufacturing of oral solid dosage forms. Notably, Shasun's forward integration capabilities allow it to combine its API's and Formulation capabilities, making it a versatile player in the industry. The company's site also serves as a platform for filing ANDA's, NDA's, NCE's, and Dossier's, complemented by the manufacture of finished dosage forms that can be labeled, packaged, and shipped directly to Customer’s warehouses, offering a One-Stop Solution. Founded in 1976, Shasun operates in the manufacturing industry, presenting an intriguing investment opportunity for venture capitalists seeking exposure to the pharmaceutical manufacturing sector.
There is no investment information
No recent news or press coverage available for Shasun.